West Pharmaceutical Services, Inc. (NYSE: WST) last traded at $353.08, down 0.20% on the session. The quote above updates while this page is open; the figures below are drawn from West Pharmaceutical Services, Inc.’s own filings and are restated only when a new one is published.
West Pharmaceutical Services, Inc. trades on NYSE under the ticker WST. Its market capitalisation is $24.85 billion.
Valuation measures for West Pharmaceutical Services, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $24.85B |
|---|---|
| Enterprise value | $25.50B |
| P/E ratio | 45.21 |
| Price / sales | 7.47 |
| Price / book | 8.31 |
| Beta | 0.66 |
Trailing-twelve-month figures tagged in West Pharmaceutical Services, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $3.33B |
|---|---|
| Net income (TTM) | $564.90M |
| EPS (TTM) | $7.81 |
| Gross margin | 36.79% |
| Operating margin | 20.45% |
| Return on equity | 18.89% |
| Cash | $435.80M |
Range and volume for WST over the past 52 weeks.
| 52-week high | $386.00 |
|---|---|
| 52-week low | $223.83 |
| Volume | 424.7K |
| Average volume | 740.0K |
| Previous close | $353.77 |
Dividend history for West Pharmaceutical Services, Inc. over the trailing twelve months.
| Dividend yield | 0.25% |
|---|---|
| Dividend per share (TTM) | $0.870 |
| Payout ratio | 11.14% |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.